Tianjin Lisheng Pharmaceutical Co.,Ltd.

002393

CNE100000NJ9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 24/05/2024 am IST			5-day change	1st Jan Change
25.59 ^CNY	+0.16%		-1.46%	-1.95%

22/05	Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 28 May 2024	CI
24/04	Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Tianjin Lisheng Pharmaceutical Co.,Ltd. Approves Executive Changes

February 01, 2022 at 01:07 am IST

Tianjin Lisheng Pharmaceutical Co.,Ltd. at its 1st Extraordinary General Meeting of 2022 on 25 February 2022, approved appointment of Zhuang Qifei, Li Jing, Xu Daoqing, Yu Kexiang, Tang Yilong as non-independent directors. Lei Ying, Fang Jianxin, Zhang Mei as independent directors. Shen Guangyan and Yang Qingwen as supervisors.

Latest news about Tianjin Lisheng Pharmaceutical Co.,Ltd.

Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 28 May 2024	22/05	CI
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
Tianjin Lisheng Pharmaceutical Co.,Ltd. Proposes Cash Dividend for the Year 2023	23/03	CI
Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4%	22/03	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02	CI
Lisheng Pharmaceutical Buys 65% Stake in Qingchun Kangyuan Pharmaceutical for 137 Million Yuan; Shares Up 3%	02/01	MT
Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan	14/12	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. agreed to acquire 65% stake in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd. from Jiangxi Qingchun Kangyuan Group Co., Ltd. and Jiangxi Qingchun Kangyuan Chinese Medicine Co., Ltd. for approximately CNY 140 million.	14/12	CI
Tianjin Lisheng Pharma Setting Up Venture Capital Fund	12/12	MT
Lisheng Pharmaceutical and Lisheng Investment Enter into the Partnership Agreement with Bozheng Capital, Tianjin Jinjia and Tianjin Handeway	11/12	CI
Tianjin Development to Vote Dec. 5 on Lisheng Pharma's Sale of Tianjin Pharmaceutical Finance Stake	10/11	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/23/29	CI
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited agreed to acquire additional 15% stake in Tianjin Pharmaceutical Group Finance Co., Ltd from Tianjin Lisheng Pharmaceutical Co.,Ltd. for CNY 87.8 million.	11/23/11	CI
Lisheng Pharmaceutical's H1 Attributable Profit Jumps	25/23/25	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Lisheng Pharmaceutical Subscribes for 20 Million Yuan Wealth Management Product	02/23/02	MT
Lisheng Pharma to Receive 247.9 Million Yuan for Relocation	26/23/26	MT
Lisheng Pharmaceutical Eyes 247.9 Million Yuan from Potential Land Resumption Deal	26/23/26	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 30 June 2023	21/23/21	CI
Tianjin Lisheng Pharma Gets Nod For Febuxostat Active Pharma Ingredient in China	15/23/15	MT
Lisheng Pharma Unit's Drug Passes Regulatory Evaluation	15/23/15	MT
Tianjin Lisheng Pharmaceutical's Q1 Attributable Profit Increases	27/23/27	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Lisheng Pharmaceutical's Audited 2022 Profit Marginally Higher Than Unaudited Results	24/23/24	MT
Tianjin Lisheng Pharmaceutical Co., Ltd. Announces the Profit Distribution Proposal for the Year 2022	24/23/24	CI

Chart Tianjin Lisheng Pharmaceutical Co.,Ltd.

Duration

Period

Chart Tianjin Lisheng Pharmaceutical Co.,Ltd.

More charts

Company Profile

Tianjin Lisheng Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the manufacture and distribution of chemical drugs. The Company's major products are tablets, hard capsules, pills, free-dry powder injections, water injections and raw drugs, including drugs for cardio and cerebral vascular systems, anti-infection drugs and hormone drugs, among others. It distributes its products mainly within domestic markets.

Sector

Pharmaceuticals

Calendar

28/05/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
TIANJIN LISHENG PHARMACEUTICAL CO.,LTD.	-1.95%	65Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+18.04%	4.29TCr
OTSUKA HOLDINGS CO., LTD.	+16.92%	2.14TCr
SANDOZ GROUP AG	+18.33%	1.51TCr
CIPLA LIMITED	+19.27%	1.44TCr
ZYDUS LIFESCIENCES LIMITED	+56.12%	1.3TCr
THE MEDICINES COMPANY	-0.05%	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-10.73%	672.16Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+11.21%	546.52Cr